158 results on '"Perrin, Lewis"'
Search Results
2. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
3. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial
4. miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer
5. Pathological process has a crucial role in sentinel node biopsy for vulvar cancer
6. Establishing the sensitivity and specificity of the gynaecological cancer distress screen.
7. Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial
8. Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high‐grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.
9. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer
10. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
11. The shift toward neo‐adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population‐based setting: Impact on clinical outcomes
12. Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer.
13. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial
14. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
15. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer
16. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
17. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma
18. Response to “Surgical management of abnormally invasive placenta: is decreased blood loss due to participation of gynecologic oncologists?”
19. Surgical management of abnormally invasive placenta: a retrospective cohort study demonstrating the benefits of a standardized operative approach
20. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
21. Re: Radical Trachelectomy for early stage cervical cancer. The Queensland experience. ANZJOG 2014; 54(5):450–452
22. Radical Trachelectomy for early stage cervical cancer: The Queensland experience
23. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation
24. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
25. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage
26. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix
27. RANDOMIZED TRIAL OF SKIN CLOSURE AFTER LAPAROTOMY FOR GYNAECOLOGICAL SURGERY
28. Total laparoscopic hysterectomy: The Brisbane learning curve
29. Prognostic Importance of Preoperative CA-125 in International Federation of Gynecology and Obstetrics Stage I Epithelial Ovarian Cancer: An Australian Multicenter Study
30. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva
31. Case Report of a Generalized Seizure Related to Paclitaxel Infusion
32. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
33. The Impact of Positive Peritoneal Washings and Serosal and Adnexal Involvement on Survival in Patients with Stage IIIA Uterine Cancer
34. A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING SUPRAPUBIC WITH URETHRAL CATHETERIZATION IN RECTAL SURGERY
35. Complete pathological response following levonorgestrel intrauterine device in clinically stage I endometrial adenocarcinoma: Results of a randomized clinical trial
36. Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151]
37. Safety and Efficacy of Low Anterior en Bloc Resection as Part of Cytoreductive Surgery for Patients with Ovarian Cancer
38. The Significance of Psammoma Bodies on Cervical Cytology Smears
39. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
40. Ovarian cancer-derived exosomes promote tumour metastasis in vivo: an effect modulated by the invasiveness capacity of their originating cells.
41. The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer.
42. Signet ring stromal cells within an ovarian serous cystadenofibroma: A potential diagnostic pitfall
43. L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.
44. Validation of the FIGO 2009 Staging System for Carcinoma of the Vulva.
45. Evaluation of Tumor-Free Distance and Depth of Myometrial Invasion as Prognostic Factors for Lymph Node Metastases in Endometrial Cancer.
46. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
47. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results.
48. Primary Bartholin gland carcinoma: a report of seven cases.
49. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors.
50. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.